Monarques Gold Corp has closed a non-brokered private placement with a Capital Mines Hydrocarbures fund managed by Ressources Québec of 12,820,513 units at $0.39 for gross proceeds of $5m.
Ressources Québec, a subsidiary of Investissement Québec, supports resource companies at every stage of their projects, from exploration and development through to processing.
Monarques president Jean-Marc Lacoste said the proceeds of the funding will go towards the firm’s multiple projects for the year, including the 50,000-metre drilling program on Beaufor and Croinor Gold, the 43-101 resource estimates on the McKenzie Break and Swanson properties and the establishment of a development strategy for the Wasamac gold deposit.
Monarques Gold Corp is an emerging gold producer focused on pursuing growth through its large portfolio of high-quality projects in the Abitibi mining camp in Quebec, Canada.
This article has been edited. It first appeared on Private Capital Journal, a site managed by CPE Media Inc, the official data provider for PCMA. Read the rest of the article here.
Click here to subscribe to the Private Capital Journal. PCMA members receive a 10% discount on all their subscriptions. Part of your subscription fee goes to support the PCMA.
Check out these subscriber-only news items on Private Capital Journal:
- Arctic Blockchain $10M financing – update
Arctic Blockchain raised $10M in private financing from Canadian and international private investors
- PureSinse secures new financing
PureSinse, a Licensed Producer under ACMPR, completed new round of financing
- Premier Tech acquires Swabo Machinebouw & Toelevering
Fonds de solidarité backed Premier Tech acquired Hapert, Netherlands based Swabo Machinebouw & Toelevering
- Spacefy secures new financing
Spacefy, an online marketplace that connects creative people with creative spaces, secured new financing
- Mojio secures additional Series B add-on funding
Mojio raised additional Series B funding from French investor Iris Capital and TELUS Ventures
- Feldan Therapeutic secures additional Series B financing
Feldan Therapeutic raised additional Series B round of funding
